Genetic testing of cancers can assist in diagnosis, prognosis, treatment options and disease monitoring.
Our US Board-Certified Molecular Genetics Pathologists are available to analyze cancer specimens in order to determine the best testing strategies for each patient.
Mutation analysis, including NGS panels, is available.
Lung cancer, e.g. EGFR and ALK mutation analysis
Colon cancer, e.g. KRAS, NRAS and BRAF
Pediatric tumors with recurrent genetic mutations, e.g. Ewing sarcoma
Testing for predisposing mutations, e.g. BRCA1 & BRCA2, and Lynch syndrome (see familial cancer)
Our partnerships with major pharmaceutical companies allow us to offer some of these tests at no cost – please contact us to find out more.